Header Logo

Connection

DOV KADMON to Androgen Antagonists

Back to Details
This is a "connection" page, showing publications DOV KADMON has written about Androgen Antagonists.
DOV KADMON
Connection Strength
0.013
Androgen Antagonists
  1. Phase I-II trial evaluating combined intensity-modulated radiotherapy and in situ gene therapy with or without hormonal therapy in treatment of prostate cancer-interim report on PSA response and biopsy data. Int J Radiat Oncol Biol Phys. 2004 Apr 01; 58(5):1520-9.
    View in: PubMed
    Score: 0.013
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.